NASDAQ:APRE

Aprea Therapeutics Stock Forecast

etoro logo Buy APRE
*Your capital is at risk
$0.715
-0.0648 (-8.31%)
At Close: Jun 18, 2026
AI Analysis AI Analysis of APRE AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add APRE to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Big movements in Aprea Therapeutics Inc. stock price on Thursday moving 10.49% between high and low
(Updated on Jun 18, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jun 17, 2026 Loss -8.31%

The Aprea Therapeutics Inc. stock price fell by -8.31% on the last day (Thursday, 18th Jun 2026) from $0.780 to $0.715. During the last trading day the stock fluctuated 10.49% from a day low at $0.715 to a day high of $0.790. The price has risen in 6 of the last 10 days but is still down by -7.78% for this period. Volume has increased on the last day by 15 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 76 thousand shares were bought and sold for approximately $54.45 thousand.

The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.688 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 3.69% during the next 3 months and, with a 90% probability hold a price between $0.714 and $1.06 at the end of this 3-month period.

APRE Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, June 12, 2026, and so far it has risen 4.21%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Aprea Therapeutics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.733 and $0.83. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Aprea Therapeutics Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Aprea Therapeutics Inc. stock

Aprea Therapeutics Inc. finds support from accumulated volume at $0.704 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0750 between high and low, or 10.49%. For the last week, the stock has had daily average volatility of 9.52%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (APRE) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Aprea Therapeutics Inc. to open at $0.740, and during the day (based on 14 day Average True Range), to move between $0.681 and $0.749, which gives a possible trading interval of +/-$0.0689 (+/-10.13%) up or down from last closing price. If Aprea Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 10.13% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.704 (1.57%) than the resistance at $0.739 (3.36%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Aprea Therapeutics Inc. stock A Buy?

The Aprea Therapeutics Inc. stock holds several negative signals and despite the positive trend, we believe Aprea Therapeutics Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -3.316 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 22, 2026 - $0.740 ( 3.50%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

APRE Performance

Trading levels for APRE

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.82 13.99%
R2 0.786 9.98%
R1 0.769 7.50%
Price 0.715
S1 0.711 -0.510%
S2 0.694 -2.99%
S3 0.665 -6.99%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.88 23.17%
R2 0.763 6.70%
R1 0.739 3.36%
Price 0.715
S1 0.704 -1.57%
S2 0.699 -2.21%
S3 0.686 -4.04%

FAQ

What is the symbol for Aprea Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Aprea Therapeutics Inc. is APRE and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Aprea Therapeutics Inc. Stock?
The Aprea Therapeutics Inc. stock holds several negative signals and despite the positive trend, we believe Aprea Therapeutics Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Aprea Therapeutics Inc. Stock?
Aprea Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Aprea Therapeutics Inc. Stock.

What's the current price of Aprea Therapeutics Inc. Stock?
As of the end of day on the Jun 18, 2026, the price of an Aprea Therapeutics Inc. (APRE) share was $0.715.

What is the 52-week high and low for Aprea Therapeutics Inc. Stock?
The 52-week high for Aprea Therapeutics Inc. Stock is $2.22 and the 52-week low is $0.548.

What is the market capitalization of Aprea Therapeutics Inc. Stock?
As of the Jun 18, 2026, the market capitalization of Aprea Therapeutics Inc. is 4.644M.

When is the next earnings date for Aprea Therapeutics Inc.?
The upcoming earnings date for Aprea Therapeutics Inc. is Aug 11, 2026.
Click to get the best stock tips daily for free!
ABOUT APREA THERAPEUTICS INC.
Aprea Therapeutics
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products pipeline also includes ATRN-Backup, an ATR inhibitor; ATRN-W1051 to treat anti-tumor activity; and ATR...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
7.76% Jun 12
DHI
$146.71
7.57% Jun 10
PHM
$118.49
7.15% Jun 10
EAT
$140.46
17.39% Jun 05
TPR
$140.47
2.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE